Commission on Cancer's Quality of Care Measures
UC San Diego Health's cancer program is accredited by the
Commission on Cancer (CoC), which collects standardized data from CoC-accredited health care settings to measure cancer care quality.
The data presented below is included in the CoC's quality of care measures for colon and rectal cancer, and are for 2015, the most recent year for which data is available. (Data provided by the National Cancer Database.)
The purpose of the data is to compare the care of colorectal cancer patients at UC San Diego Health with other CoC-accredited cancer programs regionally and nationwide. UC San Diego's results compare favorably in all below measures. For more information about quality and safety measures, see
|Adjuvant chemotherapy considered within four months of diagnosis with AJCC Stage III (lymph node positive) colon cancer (when appropriate)||
|At least 12 regional lymph nodes removed and examined for resected colon cancer||
|Chemo and radiation therapy, administered or recommended for resected rectal cancers||